RCVR (Residual CardioVascular Risk) Prospective Multicenter Study

RecruitingOBSERVATIONAL
Enrollment

1,000

Participants

Timeline

Start Date

June 17, 2024

Primary Completion Date

June 17, 2029

Study Completion Date

December 31, 2029

Conditions
Coronary Artery Disease
Interventions
DIAGNOSTIC_TEST

Blood Sample

Patients' blood samples are tested at 1 month, and then annually for 3 years post-intervention to assess residual thrombotic, metabolic, and inflammatory risk.

OTHER

DICOM Dataset

Patients' DICOM dataset is evaluated using artificial intelligence-based quantitative coronary analysis to assess a procedural risk.

Trial Locations (1)

13496

RECRUITING

CHA Bundang Medical Center, Seongnam-si

All Listed Sponsors
lead

CHA University

OTHER